Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome
NCT01310959 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 88
Last updated 2011-12-13
Summary
Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome
Conditions
- Aplastic Anemia and Other Marrow Failure Syndrome
Interventions
- OTHER
-
Database
Database
Sponsors & Collaborators
-
King Faisal Specialist Hospital & Research Center
lead OTHER
Principal Investigators
-
H Al-Zahrani, M.D. · KFSH & RC
Eligibility
- Min Age
- 14 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-31
Countries
- Saudi Arabia
Study Locations
More Related Trials
-
Unrelated Umbilical Cord Blood Following HLA-haploidentical Hematopoietic Stem Cell Transplantation in Patients With β-thalassemia Major
NCT02126046 ·Status: UNKNOWN ·Phase: NA
-
Global PNH Patient Registry
NCT05755867 ·Status: RECRUITING
-
Genetic Factors Affecting the Severity of Beta Thalassemia
NCT00159042 ·Status: COMPLETED
-
Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major
NCT00480506 ·Status: COMPLETED
-
the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia
NCT05851105 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Clinico-Epidemiological Profile Of Acquired Aplastic Anemia Among Children At Assiut Governorate .
NCT07259863 ·Status: NOT_YET_RECRUITING
-
The Congenital Dyserythropoietic Anemia Registry (CDAR)
NCT02964494 ·Status: RECRUITING
-
The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
NCT00230165 ·Status: RECRUITING
-
Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients
NCT05745532 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia
NCT05864170 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.
NCT05860595 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Screening for Alpha Thalassemia in Healthy Volunteers
NCT02692872 ·Status: ACTIVE_NOT_RECRUITING
-
Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia
NCT01362595 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
NCT01220115 ·Status: COMPLETED
-
Molecular Biology of Polycythemia and Thrombocytosis
NCT00722527 ·Status: RECRUITING
-
A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants
NCT05015920 ·Status: COMPLETED ·Phase: NA
-
National Cancer Institute Thai Cancer Anemia Survey
NCT01030159 ·Status: COMPLETED
-
Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia
NCT05577312 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease
NCT03240731 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
NCT01419704 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Screening Patients With Sickle Cell Disease for Kidney Damage
NCT02239016 ·Status: COMPLETED
-
Diamond Blackfan Anemia Registry (DBAR)
NCT00106015 ·Status: RECRUITING
-
Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag
NCT04269889 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Biological, Genetic and Environmental Involved in the Complications of Sickle Cell Disease
NCT04205123 ·Status: UNKNOWN
-
Stroke Prevention in Sickle Cell Anemia (STOP 1)
NCT00000592 ·Status: COMPLETED ·Phase: PHASE3